六味五灵片治疗非洒精性脂肪性肝病随机对照试验Meta分析  

Meta-analysis of Randomized Controlled Trials on Liuwei Wuling Tablet in Treatment of Non-Alcoholic Fatty Liver Disease

作　　者：沈荣国 徐重白[2] 严峰[2] 缪卫红[2] 夏伟[2] 李检阅[2] 

机构地区：[1]南京市江宁区方山卫生服务中心,江苏南京211110 [2]江苏省中西医结合医院,江苏南京210000

出　　处：《辽宁中医药大学学报》2015年第5期179-181,共3页Journal of Liaoning University of Traditional Chinese Medicine

基　　金：辽宁省科技厅科学技术计划项目(2010225034)

摘　　要：目的:对六味五灵片治疗非洒精性脂肪性肝病临床疗效及安全性进行Meta分析。方法:检索电子数据库包括Cochrane Central Register of Controlled Trials(CENTRAL)、Pubmed、万方数据库、中文科技期刊全文数据库、中国学术期刊全文数据库和中国生物医学文献数据库已发表的关于六味五灵片治疗非洒精性脂肪性肝病的随机对照试验。采用Review Manager 5.1软件对数据进行分析。结果:共纳入5篇文献,312名患者,研究间无明显异质性,结果显示试验组与对照组在疗效方面差异有统计学意义。结论:六味五灵片治疗非洒精性脂肪性肝病临床疗效明显优于常规治疗,较安全,值得推广应用。Objective ： To evaluate the clinical efficacy and safety of Liuwei Wuling Tablet on non- alcoholic fatty liver diseases. Methods： Retrieve relevant network databases, Coehrane Central Register of Controlled Trials （ CENTRAL ）, Pubmed, WANFANG DATA, VIP, CNKI, CBM were used.Review Manager 5.1 software was use to analyze. Results： A total of 5 studies, 312 patients had no heterogeneity between studies.The results showed that the clinical efficacy of Liuwei Wuling Tablet in the treatment of non-alcoholic fatty liver disease was significantly different between two groups. Conclusions ： Liuwei Wuling Tablet has clinical efficacy and good safety for non-alcoholic fatty liver disease, and it is worthy of clinical application.

关 键 词：六味五灵片 非洒精性脂肪性肝病 META分析 

分 类 号：R575.5[医药卫生—消化系统]